ARRay- ACE-2 Rezeptor-basierte Reagenzien als Werkzeuge zur Qualitätsbewertung von Immunoassayreagenzien und zur Entwicklung von Assays zur qualitativen Bewertung von SARS-CoV-2-spezifischen Immunantworten
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:1 publications
Grant number: 01KI20270
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$55,460.45Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
PendingResearch Location
GermanyLead Research Institution
Fraunhofer-Gesellschaft, MünchenResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Subject
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
discovery - Due to the currently high number of diagnostic tests against SARS-CoV-2 being developed, test materials, the so-called validation reagents, represent a bottleneck for the development of diagnostics. The aim of the project is to develop validation reagents for these tests that are simple and in large quantities can be produced. As such a validation reagent, the human protein ACE2 in various variants is to be produced in plant cells and tested for its suitability. If produced successfully in plant cells, the reagent could be produced simply and in large quantities if successful.
Publicationslinked via Europe PMC
Last Updated:3 days ago
View all publications at Europe PMC